Paige, a global leader in end-to-end digital pathology solutions and artificial intelligence (AI) applications, announced the launch of a new service line based on Paige’s Foundation Models, including the world's largest multi-modal AI model in pathology and oncology. AI developers, organizations building computational pathology products, and life sciences companies...
Nanite, Inc. and SalioGen Therapeutics announced a research collaboration that will utilize Nanite's SAYER™ delivery platform to develop a lung-targeting polymer nanoparticle (PNP) designed to integrate the cystic fibrosis transmembrane conductance regulator (CFTR) gene directly into lung cells using SalioGen's novel Gene Coding™ technology. Mutations in the CFTR gene cause cystic...
DataHow, a leader of AI-powered bioprocessing solutions for biopharmaceutical process development and manufacturing closes its Series A investment round.
DataHow, a leader in AI-powered solutions for bioprocess development and manufacturing, has successfully closed its Series A investment round led by Momenta, the leading industrial impact venture capital firm. This investment, along...
Inspired Chemistry™ platform eliminates manual chemical synthesis as a key bottleneck in drug discovery with automated high-throughput, multi-step synthesis to enable more complex and diverse small molecules, including those designed by AI, to be made and tested
DeepCure, a leader in discovering novel therapeutics powered by AI and automation, announced...
Domino founds SCE Coalition alongside major biopharma customers, unveils Domino Flows and RevX: Life Sciences Edition to help transform the clinical analytics field
Domino Data Lab, provider of the leading Enterprise AI platform trusted by the largest AI-driven companies, announced the launch of a new Statistical Computing Environment (SCE) Coalition...
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform (Norio Hamamatsu, President and CEO) signed a master service agreement with Daiichi Sankyo Co., Ltd. (Hiroyuki Okuzawa, President and COO). RevolKa will create and deliver highly functional proteins, in collaboration with Daiichi Sankyo Co., Ltd. by...
Owkin, the first end-to-end TechBio unicorn that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, has unveiled an innovative drug pipeline in oncology and immunology following an exclusive global licensing agreement with Idorsia to develop and commercialize OKN4395, a clinic-ready best-in-class dual inhibitor of prostanoid...
Dr. Singh brings a track record of leadership and innovation from the FDA's Oncology Center of Excellence, with deep expertise in precision medicine and clinical development
Precision for Medicine, a global leader in biomarker-driven clinical research and development, announced that Harpreet Singh, MD, has joined the company as Chief Medical Officer....
Click Therapeutics, Inc., a leader in Digital Therapeutics™ as prescription medical treatments, announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc. The assets acquired include AspyreRx (BT-001), the first FDA-authorized prescription digital therapeutic for type 2...
Red Hat, Inc., the world's leading provider of open source solutions, announced that Boston Children’s Hospital is piloting imaging analysis using Red Hat OpenShift for artificial intelligence (AI). The collaboration between Red Hat and Boston Children’s Hospital, one of the leading pediatric hospitals in the nation, is utilizing AI adoption in the...
